Introducing cashew nuts during infancy – The Cashew Study.

Not Applicable

Completed

• Conditions: Food allergy; Tree Nut Hypersensitivity; Inflammatory and Immune System - Allergies

• Registration Number: ACTRN12618000228280
• Lead Sponsor: Dr Debra Palmer

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-12
• Study Completion: 2021-08-18
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 196

Inclusion Criteria

Eligible participants will be infants who are born greater than or equal to 37 weeks gestation.

Exclusion Criteria

Infants with a feeding difficulty that are unable to eat solid foods prior to 8 months of age.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cashew nut-specific IgG4 concentration in infant blood measured using the ImmunoCAP 250 system (Phadia AB, Uppsala, Sweden)..[At 1 year of age.]

Secondary Outcome Measures

Name	Time	Method
Sensitization to cashew nut measured by cashew nut-specific IgE concentration in infant blood measured using the ImmunoCAP 250 system (Phadia AB, Uppsala, Sweden).[At 1 year of age.];Sensitization to cashew nut measured by cashew nut skin prick testing. [At 1 year of age.];Medically diagnosed cashew nut allergy by a medical officer during the medically supervised cashew nut food challenge appointment at 1 year of age. [At 1 year of age.];Medically diagnosed eczema between 6 to 12 months of age via parent self-report or via examination by a medical officer during the 1 year of age appointment.[At 1 year of age.];Medically diagnosed wheeze between 6 to 12 months of age via parent self-report or via examination by a medical officer during the 1 year of age appointment.[At 1 year of age.]